(firstQuint)Escitalopram (Lexapro) for Depression MS or ALS.

 This eight-week study aims to assess the effectiveness and tolerability of escitalopram in improving symptoms of Major Depression in patients with Amyotrophic Lateral Sclerosis (ALS) or Multiple Sclerosis (MS) as measured by the HAM-D.

 In addition, the study will assess improvement in the quality of life in patients with Major Depression and ALS or MS.

.

 Escitalopram (Lexapro) for Depression MS or ALS@highlight

The purpose of this study is to see if escitalopram (Lexapro) improves symptoms of major depressive disorder in patients who have ALS or MS.

